In a double-blind, placebo-controlled clinical trial to test the efficacy of a drug, neither the patient nor the clinician knows whether the drug being administered is the active drug or a placebo; so, the patient by him self and also induced and supported by the clinician, hinges his expectation with the active drug and the overall response to the drug gets increased.